Phase 2 Clinical Trial with an anti-allergy nasal spray confirms Cebina’s drug repurposing discovery research findings on Azelastine as a new antiviral approach
Results from a recently concluded Phase 2, double-blind, placebo-controlled, single-centre trial conducted by a research…
Pillar Biosciences and Platomics Announce Collaboration to Support EU Clinical Labs with Documentation of NGS Workflows
Pillar Biosciences, a leading provider of kitted next-generation sequencing (NGS) panels, and regulatory automation…
Three ERC Starting Grants for the University of Vienna
Funding for historian Eva-Maria Muschik, microbiologist Megan Sørensen and historical sociologist Agata Zysiak
Valneva Reports Further Positive Phase 2 Safety and Immunogenicity Results for Lyme Disease Vaccine Candidate
- Strong immune response after third yearly booster dose in children and adults
- Significant anamnestic antibody…
Archimedlife achieves ISO 27001 Certification for Information Security Management
ARCHIMEDlife, international disease-focused Medical Laboratories* in Precision Medicine for Rare Disease and Specialty…
Sandoz: Austrian Health Report 2025: Medikamente als Spielball: Versorgungssicherheit zwischen Protektionismus und Patient*innenzugang
So gesund ist Österreich & so steht es um die Medikamentenversorgung. Der Austrian Health Report 25 liefert Antworten.
enGenes to Present ‘Reprogramming E. coli’ breakthrough to Bioprocessing Network Australia
Bioprocessing solutions expert enGenes Biotech has been invited to make its first-ever appearance at the Bioprocessing…
Houskapreis 2026: B&C Privatstiftung vergibt 760.000 Euro für österreichische Spitzenforschung
Einreichung vom 1. September bis 28. Oktober 2025 unter www.houskapreis.at in drei Kategorien Hochschulforschung,…
Uni Vienna: Sustainable energy: "Fairy circles" can provide clues to the depth of natural hydrogen Sources
New study by the University of Vienna explains why 'fairy circles' subside
Überlebenschancen bei Lungenkrebs erhöhen: LBI für Lungengesundheit startet erstmals Früherkennungsprogramm in Wien
Lungenkrebs ist die häufigste Ursache krebsbedingter Todesfälle in Österreich. Die hohe Sterblichkeit ist vor allem…
Neue Leitung in Public Affairs und Market Access der Pharmig
Dr. Rainer Thomas übernimmt mit heutigem Tag die Position des „Head of Public Affairs and Market Access“ im Verband der…
Uni Vienna: Bacteria that "breathe" rocks and Sulfur
Microbiologists uncover bacteria that remove toxic sulfide and use iron minerals for growth
ACV: Kinderurologie bewahrt Organfunktion und schützt vor Erkrankungen des Harn- und Genitalsystems
Alljährlich brauchen an die 1.150 Neugeborene in Österreich eine kinderurologische Unterstützung, um angeborene…
IMP: ZNFX1 compacts and tags RNA to keep immunity in check
Tim Clausen’s lab at the IMP and collaborators have uncovered how the ancient immune protein ZNFX1 enables cells to walk…
Proxygen and EPFL Launch Strategic Collaboration to Advance AI-Driven Glue Discovery
A new partnership brings together a validated discovery platform and cutting-edge computational innovation in targeted…
LISAvienna: August 2025 newsletter available for reading online
As the summer holiday season draws to a close, we would like to take a moment not only to reflect on the past weeks but…
Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® In the U.S.
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the United States…
May Guo Appointed Vice President Business Development at Biomay
Biomay announces the appointment of May Guo as Vice President Business Development. With over 20 years of experience in…
Uni Vienna: Measuring How Molecules Communicate
New method enables direct measurement of partial charges in molecules
Boehringer Ingelheim and AnGes sign manufacturing agreement for HGF gene therapy product
- Collaboration reinforces Boehringer Ingelheim’s expertise in microbial contract development and manufacturing, as well…
AstraZeneca Österreich verstärkt Führungsteam mit Nina Winderle als Business Unit Director Respiratory, Immunology & Vaccines (RIV)
- Erfahrene Pharma-Managerin kehrt nach internationalen Stationen nach Österreich zurück und startet bei AstraZeneca
-…
Vetmeduni Wien: One Health: Antibiotika-Resistenzen gefährden Mensch und Hund
Angesichts der großen Nähe von Mensch und Tier ist die Verbreitung von Antibiotika-Resistenzen eine Bedrohung der…
Uni Vienna: Plant-based diets can reduce the risk of multimorbidity
Multimorbidity caused by cancer and cardiometabolic diseases can be reduced – regardless of age
Owkin and The Comprehensive Cancer Center of the Medical University of Vienna Announce Strategic Collaboration to Accelerate Cancer Research and Care with AI Copilot
Owkin, a leading agentic AI company, and the Comprehensive Cancer Center of the Medical University of Vienna (MedUni…
BMIMI: BM Hanke: "Neuaufstellung des Innovationsschutzes stärkt Österreichs Wettbewerbsfähigkeit"
BMIMI und aws fördern ab sofort Start-ups und KMU beim Schutz ihres geistigen Eigentums mit 2 Mio. Euro
aws: Advanced.IP – Innovation Protection for Key Technologies
Key technologies such as artificial intelligence, quantum technology, and life sciences are essential for Austria’s…
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in Canada for Individuals Aged 12 and Older
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that Health Canada has…
Uni Vienna: What Geese Teach Us About Leadership and Followers
Courage and curiosity shape the flock's collective behavior
ACV: Allergieforschung macht Hoffnung auf neuartige immunologische Therapien auch für andere Erkrankungen
Fast jeder 3. Mensch leidet an einer Allergie. Durch die Entschlüsselung der relevanten Allergene, die Allergien…
Boehringer Ingelheim: From Vienna to the world: New beacon of hope for lung cancer receives US approval
A compound developed in Vienna to treat a specific form of lung cancer has been approved in the United States of…
Vetmeduni Wien: Automatisierung in der Landwirtschaft: Bringt Künstliche Intelligenz mehr Tierwohl?
Neue Studie beleuchtet Potenziale, Herausforderungen und ethische Fragen.
Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates
- Total revenues of €97.6 million compared to €70.8 million in the first half of 2024
- Cash and cash equivalents of…
Vetmeduni Wien: Unerwünschte Nebenwirkungen: Kleintiermedizin und ihre Umweltfolgen
Wie in der Humanmedizin kommen auch in der Kleintiermedizin verschiedenste chemische Verbindungen zum therapeutischen…
Hochschule Campus Wien punktet mit modernster Ultraschall-Technik für Radiologietechnologie und Sonography
Mit dem Bachelorstudium Radiologietechnologie und dem Akademischen Hochschullehrgang Sonography bildet die Hochschule…
BMASGPK: Österreicher an der Spitze der EU-Lebensmittelsicherheit: Nikolaus Kriz wird neuer Direktor der EFSA
Mit Nikolaus Kriz übernimmt ab 1. September 2025 erneut ein österreichischer Experte die Leitung der Europäischen…
ViruSure launches pioneering viral contamination test for biopharmaceuticals using Oxford Nanopore technology
New adventitious viral agent (AVA) detection test offers rapid, sensitive, and affordable viral screening for…
Vetmeduni Vienna: Resistance genes in food: Focus on production systems
A groundbreaking work lead by FFoQSI GmbH, Vetmeduni and the University of León (Spain) investigates the antimicrobial…
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the FDA has removed…
MedUni Vienna: New endoscopy technology enables early detection of esophageal cancer
Technology reveals even the smallest pathological tissue changes, significantly improving early detection and diagnosis
Out now: IB Lab LAMA 2.0
We’ve launched a major upgrade to IB Lab LAMA, our AI solution for the assessment of lower limb alignment (LLA) and leg…
TU Wien als Innovationsmotor und Start-up-Schmiede
Die TU Wien gehört zu den führenden Hochschulen für Start-up-Gründungen im deutschsprachigen Raum.
AIT: Microbiomes are key to healthy and sustainable food systems
International review with the participation of the AIT Center for Health and Bioresources provides options for action…
Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization
Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today…
Jean-Michel Quinot Appointed COO of AOP Health
International Pharma Expertise for Sustainable Growth
Vetmeduni Vienna: Sex-specific effects of a ketogenic diet during pregnancy on mouse offspring
A recent study by the University of Veterinary Medicine, Vienna, in collaboration with the University of Paris Cité, has…
KLI: Lungenkrebs: Häufig, tödlich – und noch immer unterschätzt
Zum Weltlungenkrebstag am 1. August lenkt das KLI für Lungenforschung an der Wiener Klinik Floridsdorf den Blick auf die…
Pharmig: Bei Arzneimittel zu sparen, heißt die Versorgung und den Standort zu gefährden
Wachsender Arzneimittelbedarf und damit verbundene, höhere Ausgaben liegen nicht im Verantwortungsbereich der…
District cooling plant with innovative ice storage facility at MedUniCampus Mariannengasse goes into operation
New district cooling plant of Wien Energie also uses waste heat – CO2 savings of 1,000 tonnes per year
Resonate Bio Awarded the Austria Wirtschaftsservice’s DeepTech Pre-Seed Grant to Accelerate AI-NMR Innovation
Resonate Bio, an emerging Austrian biotech startup, is thrilled to announce it has been awarded the prestigious DeepTech…
Uni Vienna: Which signalling pathways in the cell lead to possible therapies for Parkinson's disease
New triggers for mitophagy – a self-cleaning process in cells – discovered
Eveliqure Announces Dosing of First Participants in a Phase 2b study of the ShigETEC Vaccine in Shigellosis
• Phase 2b study to assess immunogenicity and efficacy of the oral ShigETEC vaccine against Shigellosis
• Study…
Uni Vienna: The Holobiont Revolution: How wheat is becoming more climate-resilient through nature-based plant breeding and machine learning
Focus on the interaction between the microbiome and plants
enGenes Biotech GmbH: iCAP Project targets world-first continuous pDNA production
Recombinant proteins and genetics specialist CDMO enGenes Biotech has embarked on a potentially transformational project…
Neues Rektorat übernimmt die Leitung der Sigmund Freud PrivatUniversität
Entwicklung zur umfassenden Gesundheitsuniversität schreitet voran
MedUni Vienna: Fox tapeworm infections more common in Europe than previously assumed
Alveolar echinococcosis is a rare but potentially life-threatening infectious disease caused by the fox tapeworm…
MedUni Vienna: Working together against cancer: Austrian Comprehensive Cancer Network and Bavarian Centre for Cancer Research launch cooperation
Cross-border alliance for a regional cancer research and care network as part of the EU Mission Cancer
Dr. Andreas Bracher ist neuer Medical Director bei Takeda in Österreich
Mit Anfang des Monats hat Dr. Andreas Bracher die Rolle des Medical Directors bei der österreichischen Niederlassung des…
Vivaldi Biosciences Announces Issuance of U.S. Patent Enabling Rapid Manufacture of its Universal Influenza Vaccine
Vivaldi Biosciences Inc., a clinical-stage biotechnology company developing nasal spray vaccines for viral respiratory…
Hookipa Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock
HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation…
EU-Handel untergräbt Biodiversitätsziele: Von der BOKU University geleitete Studie fordert Kurswechsel bei Biomasse-Produkten
Forschungsteam der BOKU University plädiert für Biomasse-Suffizienzstrategie und faire Handelsregeln.